Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models

Richard Weaver(Servier (France)), Eric A.G. Blomme(AbbVie (United States)), Amy E. Chadwick(University of Liverpool), Ian M. Copple(University of Liverpool), Helga H.J. Gerets(UCB Pharma (Belgium)), Christopher E. Goldring(University of Liverpool), André Guillouzo(Inserm), Philip Hewitt(Merck (Germany)), Magnus Ingelman‐Sundberg(Karolinska Institutet), Klaus Gjervig Jensen(Lundbeck (Denmark)), Satu Juhila(Orion Corporation (Finland)), Ursula Klingmüller(German Cancer Research Center), Gilles Labbe(Sanofi (France)), Michael J. Liguori(AbbVie (United States)), Cerys Lovatt(GlaxoSmithKline (United Kingdom)), Paul Morgan(AstraZeneca (United Kingdom)), Dean J. Naisbitt(University of Liverpool), Raymond Pieters(Utrecht University), Jan Snoeys(Janssen (Belgium)), Bob van de Water(Leiden University), Dominic P. Williams(AstraZeneca (United Kingdom)), B. Kevin Park(University of Liverpool)
Nature Reviews Drug Discovery
November 20, 2019
10.1038/s41573-019-0048-x
Cited by 244Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis